After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Skye Bioscience Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Skye Bioscience Inc is $129.52M. A total of 2.13 million shares were traded on the day, compared to an average of 1.20M shares.
In the most recent transaction, Diep Tuan Tu sold 19,489 shares of SKYE for 4.99 per share on Nov 18 ’24. After the transaction, the Chief Development Officer now owns 82,259 company shares. In a previous transaction on Nov 15 ’24, Diep Tuan Tu sold 85 shares at 5.55 per share. SKYE shares that Chief Development Officer owns now total 101,748.
Among the insiders who sold shares, ARSENAULT KAITLYN disposed of 43,206 shares on Nov 18 ’24 at a per-share price of $4.99. This resulted in the Chief Financial Officer holding 166,342 shares of SKYE after the transaction. In another insider transaction, ARSENAULT KAITLYN sold 190 shares at $5.55 per share on Nov 15 ’24. Company shares held by the Chief Financial Officer now total 209,548.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SKYE has a high of $8.36 and a low of $1.14.
As of this writing, SKYE has an earnings estimate of -$0.3 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.31.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SKYE’s latest balance sheet shows that the firm has $8.98M in Cash & Short Term Investments as of fiscal 2021. There were $2.14M in debt and $3.91M in liabilities at the time. Its Book Value Per Share was $1.91, while its Total Shareholder’s Equity was $5.86M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SKYE is Buy with a score of 5.00.
